6533b86dfe1ef96bd12c9df6
RESEARCH PRODUCT
738P Soluble PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTN2A1 as predictive biomarkers of nivolumab response in patients with metastatic clear cell renal carcinoma
M. La MantiaAntonio RussoMarco BonoViviana BazanChiara BrandoLidia Rita CorsiniA. FiorinoLorena IncorvaiaNicole GriDaniele FanaleValerio GristinaMimma RizzoJuan L. IovannaCamillo PortaDaniel OliveGiuseppe Badalamentisubject
Oncologymedicine.medical_specialtybiologybusiness.industryHematologyOncologyInternal medicinePD-L1Clear Cell Renal Carcinomamedicinebiology.proteinIn patientNivolumabbusinessPredictive biomarkeryear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |